September 2, 2026

Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth markets Highlights Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials Includes a 60,000 sq. ft. GLP bioanalytical lab in Austin; […]

Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth markets Highlights Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials Includes a 60,000 sq. ft. GLP bioanalytical lab in Austin; […]